Abstract: These findings point toward distinct extent and trajectory of corticolimbic abnormalities associated with cognitive subtypes in psychosis, which can allow further understanding of the biological course of cognitive functioning over illness course and with treatment.
Introduction
Cognitive impairment is a hallmark of psychotic disorders like schizophrenia, often proving more debilitating than positive symptoms such as hallucinations. However, the patient population is highly heterogeneous: some individuals maintain near-normal cognitive function, while others experience sharp declines or struggle from early childhood. This study addresses whether these distinct "cognitive subtypes" are underpinned by specific structural brain anomalies and unique neural trajectories over time.
Methods and Datasets
The researchers analyzed a primary cohort of 364 subjects (225 patients with psychosis and 139 healthy controls) recruited from the Institute of Mental Health, Singapore. Patients were stratified into three subtypes based on the gap between their estimated premorbid IQ (via WRAT-3 reading tests) and current cognitive performance:
- Deteriorated: Normal early-life function followed by significant decline.
- Compromised: Impaired function both early in life and currently.
- Preserved: Relatively intact cognitive abilities.
Neuroimaging was performed using 3-T MRI to measure subcortical volumes, cortical thickness, and laterality. A longitudinal subset of 101 subjects was re-scanned after five years to track structural changes. Finally, Linear Discriminant Analysis (LDA) was applied to an independent validation set of 52 subjects to test the classification accuracy of the identified brain markers.
Key Insights and Results
Neuroprogressive vs. Neurodevelopmental Trajectories
The study revealed that the "Deteriorated" subtype is characterized by a neuroprogressive decline. This group showed the most widespread cortical thinning across all four lobes and significant bilateral hippocampal volumetric decline over the five-year follow-up period ($p < 0.001$). This progressive shrinkage was uniquely associated with worsening negative symptoms and poorer psychosocial functioning.
In contrast, the "Compromised" subtype appears to follow a neurodevelopmental trajectory. This group exhibited increased rightward amygdala lateralization ($p = 0.021$), a marker often established early in life, suggesting that their cognitive impairment stems from early developmental hits rather than progressive tissue loss.
Biological Validity and Classification
The biological reality of these subtypes was supported by the classification model. Using a limited set of markers—including the hippocampus, ventricles, thalamus, and amygdala laterality—the researchers achieved 71% overall accuracy in classifying subtypes within the independent cohort. The model was particularly effective at identifying healthy controls (90% accuracy).
Discussion and Limitations
These findings suggest that treating psychosis as a monolithic condition overlooks critical biological differences. Identifying a patient's cognitive subtype could eventually allow clinicians to predict disease progression and tailor interventions more effectively.
However, the study has limitations. The use of reading tests as a proxy for premorbid IQ can be influenced by illness onset. Additionally, while the total sample size is robust, the longitudinal and validation subsets are more modest. Future research should include adolescent populations to capture the earliest emergence of these neural anomalies and utilize functional MRI to explore how structural changes impact real-time brain connectivity.
Summary updated